First Eagle Investment Management
UTHR icon

First Eagle Investment Management’s United Therapeutics UTHR Stock Holding History

First Eagle Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-548,807
Closed -$72M – 343
2015
Q3 		$72M Buy
548,807
+121,927
+29% +$19.6M 0.18% 112
2015
Q2 		$74.3M Buy
426,880
+54,300
+15% +$9.77M 0.18% 107
2015
Q1 		$64.2M Buy
372,580
+12,400
+3% +$1.89M 0.15% 115
2014
Q4 		$46.6M Buy
360,180
+98,100
+37% +$12.6M 0.11% 128
2014
Q3 		$33.7M Buy
+262,080
New +$27M 0.08% 138

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

First Eagle Investment Management's UTHR Position: Q4 2015 in Review

First Eagle Investment Management sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 548,807 shares — an estimated $72M sold.

First Eagle Investment Management first reported a position in UTHR in Q3 2014 and held it in 5 quarters. The position peaked at $74.3M in Q2 2015. 387 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • First Eagle Investment Management reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • First Eagle Investment Management sold 548,807 United Therapeutics shares in Q4 2015, an estimated $72M.
  • First Eagle Investment Management first reported a position in United Therapeutics in Q3 2014 and held it in 5 quarters.
  • First Eagle Investment Management's United Therapeutics position peaked at $74.3M in Q2 2015.
  • 387 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on First Eagle Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.